No major impact of insertion/deletion polymorphism of the angiotensin-converting enzyme gene on thyroid-associated ophthalmopathy
暂无分享,去创建一个
[1] D Crisan,et al. Angiotensin I-Converting Enzyme Genotype and Disease Associations , 2000 .
[2] Michael H. Kutner. Applied Linear Statistical Models , 1974 .
[3] J.C.G. Goelz,et al. Development of a well-behaved site index equation: jack pine in north central Ontario , 1992 .
[4] J. G. González,et al. Ecoregional site index models for Pinus pinaster in Galicia (northwestern Spain) , 2005 .
[5] D. Vaughan,et al. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. , 2000, Circulation.
[6] K. Rennolls,et al. Timber Management-A Quantitative Approach. , 1984 .
[7] F. Raulier,et al. Predicting site index from climatic, edaphic, and stand structural properties for seven plantation- grown conifer species in Quebec , 2011 .
[8] J. Egido,et al. Inflammation and angiotensin II. , 2003, The international journal of biochemistry & cell biology.
[9] H. Burkhart,et al. Suggestions for choosing an appropriate level for modelling forest stands. , 2003 .
[10] S. Pallardy,et al. Biomass production by two-year-old poplar clones on floodplain sites in the Lower Midwest, USA , 2003, Agroforestry Systems.
[11] T. Johansson. Site index curves for European aspen (Populus tremula L.) growing on forest land of different soils in Sweden. , 1996 .
[12] W. H. Carmean,et al. Forest Site Quality Evaluation in The United States , 1975 .
[13] G Chatellier,et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.
[14] William H. Press,et al. Numerical Recipes in Pascal , 2007 .
[15] Marc E. McDill,et al. Measuring Forest Site Quality Using the Parameters of a Dimensionally Compatible Height Growth Function , 1992 .
[16] R. Calama,et al. Inter-regional variability in site index models for even-aged stands of stone pine (Pinus pinea L.) in Spain , 2003 .
[17] E. Campos,et al. The ocular surface in thyroid diseases , 2010, Current opinion in allergy and clinical immunology.
[18] Oscar García,et al. A Stochastic Differential Equation Model for the Height Growth of Forest Stands , 1983 .
[19] S. Werner. Modification of the classification of the eye changes of Graves' disease. , 1977, American journal of ophthalmology.
[20] R. Curtis,et al. Which Dependent Variable in Site Index-Height-Age Regressions? , 1974 .
[21] Bernard R. Parresol,et al. White Pine Site Index for the Southern Forest Survey , 1998 .
[22] D. M. Smith,et al. The Practice Of Silviculture: Applied Forest Ecology , 2014 .
[23] H. Ayadi,et al. Autoimmune thyroid diseases: genetic susceptibility of thyroid‐specific genes and thyroid autoantigens contributions , 2009, International journal of immunogenetics.
[24] U. Das. Is angiotensin-II an endogenous pro-inflammatory molecule? , 2005, Medical science monitor : international medical journal of experimental and clinical research.
[25] R. Müllenbach,et al. An efficient salt-chloroform extraction of DNA from blood and tissues. , 1989, Trends in genetics : TIG.
[26] M. Moini,et al. Potential benefit of angiotensin converting enzyme inhibitors for hindering progression of Graves' ophthalmopathy. , 2008, Medical hypotheses.
[27] Y. Shoenfeld,et al. Coexistence of thyroid autoimmunity with other autoimmune diseases: Friend or foe? Additional aspects on the mosaic of autoimmunity , 2005, Autoimmunity.
[28] B. Yalcin,et al. The role of preoperative serum thyroglobulin and thyroid auto-antibody levels before histopathological diagnosis of thyroid cancers , 2011, Turkish Journal of Medical Sciences.
[29] N. Draper,et al. Applied Regression Analysis , 1966 .
[30] M. Rudnicki,et al. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. , 2009, Pharmacogenomics.
[31] Chris J. Cieszewski,et al. Developing a well-behaved dynamic site equation using a modified Hossfeld IV function y3 = (axm)/(c + xm-1), a simplified mixed-model and scant subalpine fir data , 2003 .
[32] Philip J. McCarthy,et al. The Use of Balanced Half-Sample Replication in Cross-Validation Studies , 1976 .
[33] L. S. Davis. Forest Management: To Sustain Ecological, Economic, and Social Values , 2005 .
[34] C. Marcocci,et al. Management of Graves' ophthalmopathy: reality and perspectives. , 2000, Endocrine reviews.
[35] A. Kızıltunç,et al. Serum IL-6 and TNF-\alpha in Patients With Thyroid Disorders , 1999 .
[36] R. de Caterina,et al. Aspects of gene polymorphisms in cardiovascular disease: the renin‐angiotensin system , 2001, European journal of clinical investigation.
[37] Robert L. Bailey,et al. Base-Age Invariant Polymorphic Site Curves , 1974 .
[38] U. Diéguez-Aranda,et al. Site quality equations for Pinus sylvestris L. plantations in Galicia (northwestern Spain) , 2005 .
[39] J. Staessen,et al. Genetic Variability in the Renin-Angiotensin System: Prevalence of Alleles and Genotypes , 1997, Journal of cardiovascular risk.
[40] H. Saya,et al. Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction* , 2009, The Journal of Biological Chemistry.
[41] E. Karoutsou,et al. Pathogenesis of Graves' disease focusing on Graves' ophthalmopathy. , 2011, Endocrine regulations.
[42] G. Remuzzi,et al. Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[43] J. D. Newberry. A note on Carmean's estimate of height from stem analysis data , 1991 .
[44] H. Vapaatalo,et al. Local ocular renin-angiotensin system - a target for glaucoma therapy? , 2011, Basic & clinical pharmacology & toxicology.
[45] A. Granström,et al. Aggregations of dead wood after wildfire act as browsing refugia for seedlings of Populus tremula and Salix caprea , 2007 .
[46] Yuan Zhang,et al. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition. , 2006, Diabetes care.
[47] M. Cengiz,et al. Genetic polymorphism of angiotensin I‐converting enzyme (ACE), but not angiotensin II type I receptor (ATr1), has a gender‐specific role in panic disorder , 2012, Psychiatry and clinical neurosciences.
[48] A. Berdeli,et al. Prevalence of the Angiotensin I Converting Enzyme Gene Insertion/Deletion Polymorphism in a Healthy Turkish Population , 2009, Biochemical Genetics.
[49] F. Fyhrquist,et al. Renin‐angiotensin system revisited , 2008, Journal of internal medicine.
[50] W. Wiersinga,et al. Epidemiology and prevention of Graves' ophthalmopathy. , 2002, Thyroid : official journal of the American Thyroid Association.
[51] W. H. Carmean,et al. Site Index Curves for Upland Oaks in the Central States , 1972 .
[52] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[53] N. Draper,et al. Applied Regression Analysis , 1967 .
[54] N. Samani,et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. , 1996, Circulation.